WHO-GMP APPROVED PHARMACEUTICAL MANUFACTURING UNIT FOR FULL SALE IN DELHI
Key financials
Annual revenue
₹80 Cr
EBITDA
—
Net worth
—
Expected deal value
—
Business overview
Strategic opportunity to acquire a 100% stake in a premier, fully operational, export-oriented pharmaceutical manufacturing unit located in Delhi. Established in 2005 and thoroughly upgraded with a comprehensive renovation in 2022, the facility operates with an experienced team of 170 professionals. The company features a vast global and domestic footprint, proudly serving over 1,000 satisfied corporate clients. The transaction is structured as a full sale that encompasses the entire business entity, all regulatory licenses, active stock, and the underlying high-value industrial real estate asset. The current promoter is seeking a complete exit due to relocation plans.
Key strengths
- • Elite regulatory compliance framework with active WHO-GMP, GLP, ISO-9001-2015, and Schedule-M certifications
- • Strong asset backing with ₹45 Crore worth of self-owned real estate included in the deal value
- • Diversified global footprint with active export pipelines to Afghanistan, Sri Lanka, Myanmar, Yemen, Uzbekistan, Nepal, Maldives, and Ghana
- • Vast domestic and global client network serving a stable pool of over 1,000 satisfied B2B buyers
- • Large, robust formulation portfolio containing more than 250 generic product composition approvals
- • Modernized facility infrastructure following full-scale machinery and plant renovations completed in 2022
Growth opportunities for a buyer
- • High capacity headroom across the 5 production lines to scale contract manufacturing volumes
- • Opportunity to target high-margin Western or regulated markets by leveraging the updated WHO-GMP infrastructure
- • Capacity to commercialize underutilized generic composition approvals out of the existing 250+ portfolio list
- • Scope to introduce new high-value dosage forms within the spacious 3-block layout footprint
Listing details
Disclaimer: MergeAxis acts as a marketplace facilitator only. All information is provided by the Partner and has not been independently verified by MergeAxis. Conduct your own due diligence before making any investment decisions.
Similar listings
Profitable FMCG distribution firm with established retail network
Expected deal value
₹35 L
Logistics Fleet — 28 Vehicles with Long-term Contracts
Expected deal value
₹38 L